| Dr Daniel Rachlin, PHD | |
|
130 Hillcrest Dr, Suite 107, Clarksville, TN 37043-5000 | |
| (931) 553-8500 | |
| (931) 553-8544 |
| Full Name | Dr Daniel Rachlin |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 130 Hillcrest Dr, Clarksville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124029251 | NPI | - | NPPES |
| 4040536 | Other | TN | BLUE CROSS BLUE SHIELD |
| 271312000 | Other | TN | MAGELLAN BEHAVIORAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 2472 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Rachlin, PHD 130 Hillcrest Dr Ste 103, Clarksville, TN 37043-5064 Ph: (931) 542-6463 | Dr Daniel Rachlin, PHD 130 Hillcrest Dr, Suite 107, Clarksville, TN 37043-5000 Ph: (931) 553-8500 |
News Archive
A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.
Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government support is lacking. But there may be a solution to this vaccine crisis with the ability to save at-risk populations, according to a perspective piece written by physicians based at Princeton University, University of Pennsylvania and the Wellcome Trust.
For starters, reports say the proposed rule for the measure's health exchanges is due out July 7. In addition, indications are that many public health provisions remain unfunded and movement toward electronic health records is still slow.
A new study shows drinking low-fat milk - both nonfat and 1% milk - is significantly associated with less aging in adults.
Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.
› Verified 2 days ago
Tina Nicole Parker, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 118 Union St, Clarksville, TN 37040 Phone: 931-647-8257 Fax: 931-647-2978 | |
Mr. Matthew Kent Couts, BS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 511 8th St, Clarksville, TN 37040 Phone: 931-920-7200 Fax: 931-920-7205 | |
Mrs. Dannie Harris, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1064 S Riverside Dr Ste D, Clarksville, TN 37040 Phone: 931-217-1833 | |
Dr. Salvatore Zingale, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 130 Hillcrest Dr, Suite 112, Clarksville, TN 37043 Phone: 931-551-8400 Fax: 931-358-5805 | |
Dr. Leslie Marie Belt, PH.D., LCSW Psychologist Medicare: Not Enrolled in Medicare Practice Location: 782 Weatherly Dr, Clarksville, TN 37043 Phone: 931-645-3552 | |
Dr. Pamela R Pennington, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1854 Memorial Drive, Clarksville, TN 37043 Phone: 931-552-2387 Fax: 931-645-4177 |